2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor- and neuroprotector of brain in closed head injury
1. The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF- ), in the reduction of edema caused by closed head injury, in the reduction of neurological deficits caused by closed head injury and stroke and in treating pathological conditio...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
20.05.2003
|
Online Access | Get full text |
Cover
Loading…
Abstract | 1. The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF- ), in the reduction of edema caused by closed head injury, in the reduction of neurological deficits caused by closed head injury and stroke and in treating pathological conditions caused by TNF- and/or by radical oxgen intermediates (ROI), in pharmaceutical composition for the same use comprising as active ingredient 2-AG, the use of 2-AG and pharmaceutical compositions comprising same in the preparation of a medicament for the treatment of said indications and methods of treatment by 2-AG and pharmaceutical compositions comprising same for diseases caused by said indications.
The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF- ), in the reduction of edema caused by closed head injury, in the reduction of neurological deficits caused by closed head injury and stroke and in treating pathological conditions caused by TNF- and/or by radical oxygen intermediates (ROI), in pharmaceutical composition for the same use comprising as active ingredient 2-AG. It comprises also the use of 2-AG and pharmaceutical compositions comprising same in the preparation of a medicament for the treatment of said indications and methods of treatment by 2-AG and pharmaceutical compositions comprising same for diseases caused by said indications. |
---|---|
AbstractList | 1. The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF- ), in the reduction of edema caused by closed head injury, in the reduction of neurological deficits caused by closed head injury and stroke and in treating pathological conditions caused by TNF- and/or by radical oxgen intermediates (ROI), in pharmaceutical composition for the same use comprising as active ingredient 2-AG, the use of 2-AG and pharmaceutical compositions comprising same in the preparation of a medicament for the treatment of said indications and methods of treatment by 2-AG and pharmaceutical compositions comprising same for diseases caused by said indications.
The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF- ), in the reduction of edema caused by closed head injury, in the reduction of neurological deficits caused by closed head injury and stroke and in treating pathological conditions caused by TNF- and/or by radical oxygen intermediates (ROI), in pharmaceutical composition for the same use comprising as active ingredient 2-AG. It comprises also the use of 2-AG and pharmaceutical compositions comprising same in the preparation of a medicament for the treatment of said indications and methods of treatment by 2-AG and pharmaceutical compositions comprising same for diseases caused by said indications. |
Author | Panikashvili, David Breuer, Aviva Gallily, Ruth Shohami, Esther Mechoulam, Raphael |
Author_xml | – sequence: 1 fullname: Mechoulam, Raphael – sequence: 2 fullname: Gallily, Ruth – sequence: 3 fullname: Breuer, Aviva – sequence: 4 fullname: Shohami, Esther – sequence: 5 fullname: Panikashvili, David |
BookMark | eNqNizkOwjAQRVNAwXaHKaGwhAJJjxDLAejRxJ4kRsYTje0it8eRcgCqv72_LhaePa2KVCoU1L017EfXuVGTsIN9qS6Pg0IP1ve2sZEFuIWYvtl40sLBBmhR50EBepPLJDwIR9Iz3Aja6Q_acSADPaHJ8ZNk3BbLFl2g3aybAu631_WpUhgwko_h3QlOcqyruq7Op9MfyA8uVEbZ |
ContentType | Patent |
CorporateAuthor | Yissum Research Development Company of The Hebrew University of Jerusalem |
CorporateAuthor_xml | – name: Yissum Research Development Company of The Hebrew University of Jerusalem |
DBID | EFH |
DatabaseName | USPTO Issued Patents |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EFH name: USPTO Issued Patents url: http://www.uspto.gov/patft/index.html sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
ExternalDocumentID | 06566543 |
GroupedDBID | EFH |
ID | FETCH-uspatents_grants_065665433 |
IEDL.DBID | EFH |
IngestDate | Sun Mar 05 22:30:37 EST 2023 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-uspatents_grants_065665433 |
OpenAccessLink | https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6566543 |
ParticipantIDs | uspatents_grants_06566543 |
PatentNumber | 6566543 |
PublicationCentury | 2000 |
PublicationDate | 20030520 |
PublicationDateYYYYMMDD | 2003-05-20 |
PublicationDate_xml | – month: 05 year: 2003 text: 20030520 day: 20 |
PublicationDecade | 2000 |
PublicationYear | 2003 |
References | (0505817) 19920900 (9951560) 19991000 German et al. (5456912) 19951000 Di Marzo, V. et al: Cannabimimetic Fatty Acid Derivatives in Cancer and Inflammation; Prostaglandins and Other Lipid Mediators, vol. 61, Nos. 1-2, pp. 43-61, XP004197447. Sinor, A.D. et al.: "Endocannabinoids Protect Cerebral Cortical Neurons From In Vitro Ischemia in Rats"; Neuroscience Letters, vol. 278, No. 3, Jan. 14, 2000; pp. 157-160, XP002205898. |
References_xml | – year: 19991000 ident: 9951560 – year: 19951000 ident: 5456912 contributor: fullname: German et al. – year: 19920900 ident: 0505817 |
Score | 2.5670104 |
Snippet | 1. The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF- ), in the reduction of edema caused... |
SourceID | uspatents |
SourceType | Open Access Repository |
Title | 2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor- and neuroprotector of brain in closed head injury |
URI | https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6566543 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH9sQ1BPioqbH-TgQQ_Rrk3X7iiyWQRlB4XdRtOXbpUuGf1A_O99acfword885LwPgK__B7ADZLTG_oUuXmpJdWOZcjD8UjxscAAcYiBn9i_w69vo-hDvMz9eQei3V-YNakR35As5X1dbirTgCvJvLcXz1vyZ8sRqC37wJfOTYwzTB9sXOILrwvd0LHQrsk0OoR9WoJCNl2Vv5zG9Aj2Zk3rMXSUPoHa5ZYbeZWhBYMv8-9EFSZnty5_fL7jsWaZXmWSFKxgJmVVvaaCVtaLZSVr0-JwRu9-1lBQbvkV2sHS5nmg-SzJTamQkYFFqn7SeZ0Cm07enyK-k3GxLCz2ZeFs9-KdQU8brc6BpYEnpcJUqkAIkWAs0iSWqGKBrhPKpA_9P5cZ_NN3AQcNOs3xSV0uoVcVtboiL1vJ6-YIfwCBbYuM |
link.rule.ids | 230,309,786,808,891,64396 |
linkProvider | USPTO |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JTsMwEB2VglhOIECU1QcOcDC0jdOkRwQNYat6AKm3Ks44bVDqVFmE-HvGSVVxgZt3eRu_sTTzBuASCfQ6NmluVmRItQPpcrffU7wv0EHsoGOHxnf4bdjzP8Tz2B43wF_5wsxJjPiC5pLflPmiSCvjSnre64PnNfmz4QjUhn3gSydpgCOMbo1eYgtrDdYNxpq7PvD8HdiiQUhp00X-Cza8XdgYVaV70FB6H8ouN-zIsxiNOfg0-Q5VlibsqsvvHq95oFmsZ7EkEctYGrGinFNCK4Njcc7qwDic0c-fVSSUS4aFurE0kR6oPwuTNFfI6IlFyn7Sjh0A8wbv9z5fzXEyzYz1y6S9XI11CE2danUELHIsKRVGUjlCiBADEYWBRBUI7LZdGbag9ecwx__UXcDm6MGbvD4NX05guzJVa9skO6fQLLJSnRHkFvK82s0fe6-OiA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2-arachidonylglycerol+%282-AG%29-an+inhibitor+of+tumor+necrosis+factor-+and+neuroprotector+of+brain+in+closed+head+injury&rft.inventor=Mechoulam%2C+Raphael&rft.inventor=Gallily%2C+Ruth&rft.inventor=Breuer%2C+Aviva&rft.inventor=Shohami%2C+Esther&rft.inventor=Panikashvili%2C+David&rft.number=6566543&rft.date=2003-05-20&rft.externalDBID=n%2Fa&rft.externalDocID=06566543 |